Medical device manufacturers see little impact from Fiona on operations in Puerto Rico

Register now for FREE unlimited access to Reuters.com Register Sept. 23 (Reuters) – Medical device companies and some drug makers with manufacturing operations in Puerto Rico said they don’t expect significant disruption from Hurricane Fiona, which cut power to more than 3 million people and caused flooding and landslides on the island. The U.S. Food … Read more

Exclusive: Medical journals broaden investigation into possible misconduct in heart research

WASHINGTON, Sept. 13 (Reuters) – Three medical journals recently launched independent investigations into possible data manipulation in heart studies led by Temple University researchers, Reuters has learned, adding a new inquiry to an investigation into misconduct by the university and the U.S. government. The Journal of Molecular and Cellular Cardiology and the Journal of Biological … Read more

Biden Praises ‘Cancer Moonshot’ at JFK Speech Birthday in Boston

Register now for FREE unlimited access to Reuters.com Register BOSTON, Sept. 12 (Reuters) – President Joe Biden signed orders Monday to push more government dollars into the US biotechnology industry while promoting his initiative to create new treatments and reduce cancer deaths. Cancer “doesn’t matter if you’re Republican or Democrat,” Biden said at the John … Read more

Wall Street poised for higher opening as focus shifts to inflation data

Register now for FREE unlimited access to Reuters.com Register Already eyes on August CPI report on Tuesday Bristol Myers Rises on FDA Approval for Psoriasis Drug Twitter Says Musk’s Latest Attempt To Undo the Deal Is Void Futures up: Dow 0.08%, S&P 0.30%, Nasdaq 0.26% 12 Sept. (Reuters) – US stock indices were set to … Read more

Top scientists join forces to study leading theory behind COVID-19 long

A patient suffering from Lung COVID is examined at the post-coronavirus disease (COVID-19) clinic of Ichilov Hospital in Tel Aviv, Israel, Feb. 21, 2022. Photo taken Feb. 21, 2022. REUTERS/Amir Cohen/File Photo Register now for FREE unlimited access to Reuters.com Register CHICAGO, Sept. 8 (Reuters) – Top scientists from leading academic centers are teaming up … Read more

Musk sends new letter to scrap Twitter deal after whistleblower claims

Register now for FREE unlimited access to Reuters.com Register Aug 30 (Reuters) – Elon Musk has sent a supplementary deal termination letter to Twitter Inc (TWTR.N) to include a recent whistleblower complaint from the former social media company’s chief security officer as an additional reason to close the $deal deal. 44 billion to be scrapped. … Read more

Moderna sues Pfizer/BioNTech for patent infringement on COVID vaccine

Moderna’s logo is reflected in a drop on a hypodermic needle in this illustration, taken Nov. 9, 2020. REUTERS/Dado Ruvic/Illustration Register now for FREE unlimited access to Reuters.com Register Aug 26 (Reuters) – Moderna on Friday sued Pfizer and its German partner BioNTech for patent infringement in developing the first COVID-19 vaccine approved in the … Read more

Hiring and Data: How the US Will Set Up New Talks on the Price of Medicare Drugs

WASHINGTON, Aug. 22 (Reuters) – The U.S. government will soon begin hiring experts and collecting the data needed to begin direct negotiations on the prices of prescription drugs for the elderly and the disabled, a top official at the United Nations said. government of Biden to Reuters. President Joe Biden signed the Inflation Reduction Act … Read more

Bluebird’s $2.8M Gene Therapy Becomes Most Expensive Drug After U.S. Approval

Signage is on display outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, Aug. 29, 2020. REUTERS/Andrew Kelly/File Photo Register now for FREE unlimited access to Reuters.com Register Aug 17 (Reuters) – The U.S. Food and Drug Administration on Wednesday approved bluebird bios (BLUE.O) gene therapy for patients with a rare … Read more

Newly launched US drugs will hit record high prices in 2022

The Average Annual Price for New U.S. Drugs This Year Is $257,000 Eight of the 13 drugs launched in 2022 cost more than $200,000 a year Some drug manufacturers reveal less information about prices Aug 15 (Reuters) – Drug makers are launching new drugs at record prices this year, a Reuters analysis finds, highlighting their … Read more